← Open Payments lookup

EDWARD GLAZEBROOK: Open Payments

NPI 1447919535 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,814 in 160 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $1,166 · 2025 $3,814

Food & beverage: $3,814
CompanyPaymentsAmount
Lilly USA, LLC19$494
Teva Pharmaceuticals USA, Inc.16$468
ABBVIE INC.16$357
AstraZeneca Pharmaceuticals LP12$301
Otsuka America Pharmaceutical, Inc.13$245
Gilead Sciences, Inc.9$243
Neurocrine BioSciences, Inc.7$183
Exact Sciences Corporation7$159
Biogen, Inc.7$135
Sumitomo Pharma America, Inc.6$134

Products named: AUSTEDO XR, MOUNJARO, VRAYLAR, REXULTI, INGREZZA, Cologuard Collection Kit, LEQEMBI, GEMTESA.

Industry payments across MA — which companies pay providers there.